CN Patent

CN102438592B — 甲氧萘普酸的剂型

Assigned to Iceutica Pty Ltd · Expires 2016-09-14 · 10y expired

What this patent protects

本发明涉及使用干磨法制备甲氧萘普酸颗粒的方法以及包含甲氧萘普酸的组合物、使用颗粒形式的甲氧萘普酸和/或组合物制备的药物，并且涉及使用治疗有效量的通过所述药物施用的甲氧萘普酸治疗动物(包括人)的方法。

USPTO Abstract

本发明涉及使用干磨法制备甲氧萘普酸颗粒的方法以及包含甲氧萘普酸的组合物、使用颗粒形式的甲氧萘普酸和/或组合物制备的药物，并且涉及使用治疗有效量的通过所述药物施用的甲氧萘普酸治疗动物(包括人)的方法。

Drugs covered by this patent

dextromethorphan-hydrobromide (DEXTROMETHORPHAN HYDROBROMIDE)

Patent Metadata

Patent number: CN102438592B
Jurisdiction: CN
Classification: —
Expires: 2016-09-14
Drug substance claim: No
Drug product claim: No
Assignee: Iceutica Pty Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.